Repligen Corp. engages on the development, production and commercialization of products used in the process of manufacturing biological drugs. It offers upstream solutions, downstream solutions, and analytics. The upstream solutions offers XCell ATF System and cell culture supplements. The downstream solutions includes OPUS pre-packaged chromatography columns; Protein A affinity resins; and Protein A Ligands. The analytics involves ELISA kits. The company was founded by Alexander G. Rich in May 1981 and is headquartered in Waltham, MA.
